Table 2.
Distribution of Haplotype
| Haplotype | Patients with laryngeal cancer | Controls | OR (95% CI) | p value |
|---|---|---|---|---|
| Block 1 | ||||
| C C A* | 79.63 (0.170) | 15.95 (0.035) | 5.707 (3.277–9.938) | <0.001 |
| C G A* | 33.34 (0.071) | 39.65 (0.086) | 0.813 (0.503–1.313) | 0.396 |
| T C A* | 31.37 (0.067) | 37.42 (0.081) | 0.811 (0.495–1.328) | 0.404 |
| T G A* | 219.66 (0.469) | 289.99 (0.630) | 0.518 (0.398–0.673) | <0.001 |
| T G G* | 103.97 (0.222) | 28.37 (0.062) | 4.344 (2.804–6.732) | <0.001 |
| Block 2 | ||||
| A C A* | 106.97 (0.229) | 71.99 (0.157) | 1.615 (1.159–2.250) | 0.004 |
| A C C* | 43.92 (0.094) | 115.01 (0.250) | 0.314 (0.215–0.457) | <0.001 |
| A G C* | 211.19 (0.451) | 195.98 (0.426) | 1.126 (0.868–1.460) | 0.372 |
| G G A* | 22.11 (0.047) | 26.99 (0.059) | 0.803 (0.451–1.430) | 0.455 |
| G G C* | 79.77 (0.170) | 50.01 (0.109) | 1.702 (1.164–2.489) | 0.005 |
OR, odds ratio; CI, confidence interval.